AEFC

AEFC Financing Cash Flow

-€3.16BTTM · EUR

Period ending:

AEFC FY Cash from FinancingEUR
AEFC FY Cash from Financing1991-12-31: -€1.08B1992-12-31: -€680.64M1993-12-31: -€1.42B1994-12-31: -€1.66B1995-12-31: -€3.35B1996-12-31: €162.32M1997-12-31: €676.63M1998-12-31: -€2.92B1999-12-31: €2.37B2000-12-31: €3.75B2001-12-31: €9.44B2002-12-31: €523.00M2003-12-31: €872.00M2004-12-31: €530.00M2005-12-31: -€1.01B2006-12-31: -€874.00M2007-12-31: -€699.00M2008-12-31: €1.46B2009-12-31: €1.76B2010-12-31: €119.00M2011-12-31: -€374.00M2012-12-31: €2.60B2013-12-31: -€2.55B2014-12-31: €715.00M2015-12-31: -€2.79B2016-12-31: -€457.00M2017-12-31: €519.00M2018-12-31: -€2.40B2019-12-31: -€3.73B2020-12-31: -€778.00M2021-12-31: €300.00M2022-12-31: -€1.92B2023-12-31: -€3.24B2024-12-31: -€1.76B2025-12-31: -€2.01B€9.44B-€3.73B
1991-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in EUR. Dates are period ends; a fiscal year may differ from a calendar year.

AEFC financing cash flow history

Cash from issuing/repaying debt and equity. The available annual fiscal periods series contains 35 observations from Dec 31, 1991 to Dec 31, 2025.

Aegon Funding Company LLC 5.10% Subordinated Notes due 2049 Financing Cash Flow — Annual fiscal periods (EUR)
Period endingFinancing Cash Flow (EUR)
-2,005,000,000
-1,755,000,000
-3,241,000,000
-1,920,000,000
300,000,000
-778,000,000
-3,730,000,000
-2,395,000,000
519,000,000
-457,000,000
-2,785,000,000
715,000,000
-2,552,000,000
2,602,000,000
-374,000,000
119,000,000
1,756,000,000
1,461,000,000
-699,000,000
-874,000,000
-1,005,000,000
530,000,000
872,000,000
523,000,000
9,442,000,000
3,748,000,000
2,374,000,000
-2,920,885,100
676,626,880
162,319,760
-3,347,326,380
-1,655,490,720
-1,422,916,488
-680,639,414
-1,084,721,049

Compare financing cash flow

All AEFC financial metrics · AEFC stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.